Nissay Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.38M | Buy |
77,046
+5,774
| +8% | +$403K | 0.03% | 312 |
|
|
2025
Q1 | $5.24M | Buy |
71,272
+12,059
| +20% | +$886K | 0.03% | 312 |
|
|
2024
Q4 | $3.92M | Buy |
59,213
+7,008
| +13% | +$464K | 0.02% | 366 |
|
|
2024
Q3 | $4.07M | Buy |
52,205
+8,194
| +19% | +$638K | 0.03% | 365 |
|
|
2024
Q2 | $3.43M | Buy |
44,011
+10,585
| +32% | +$826K | 0.02% | 380 |
|
|
2024
Q1 | $2.26M | Buy |
33,426
+23,590
| +240% | +$1.6M | 0.02% | 473 |
|
|
2023
Q4 | $662K | Buy |
9,836
+5,032
| +105% | +$339K | 0.01% | 667 |
|
|
2023
Q3 | $325K | Buy |
+4,804
| New | +$325K | ﹤0.01% | 725 |
|